20
Participants
Start Date
December 8, 2021
Primary Completion Date
September 30, 2025
Study Completion Date
March 31, 2026
X-PACT
X-PACT is comprised of a phosphor device, the drug methoxsalen sterile solution and X-ray energy. The dose of methoxsalen sterile solution per injection will vary per patient and will remained fixed across injections within each patient as it is based on the applicable tumor volume at baseline. Immediately after each injection of the combination product, patients will be exposed to an X-ray beam delivered via a LINAC (and thus targeted at the tumor) at a fixed dose to activate the combination product.
RECRUITING
Sibley Hospital - Johns Hopkins University, Washington D.C.
RECRUITING
Duke University, Durham
RECRUITING
Levine Cancer Institute, Charlotte
RECRUITING
Prisma Health, Greenville
Immunolight, LLC
INDUSTRY